Pubblicazioni

Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats.  (2007)

Autori:
Dalle Carbonare, Luca Giuseppe; Bertoldo, Francesco; Valenti, Maria Teresa; Zordan, S.; Sella, S.; Fassina, A.; Turco, G.; Realdi, G.; Lo Cascio, Vincenzo; Giannini, S.
Titolo:
Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats.
Anno:
2007
Tipologia prodotto:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Lingua:
Inglese
Referee:
No
Nome rivista:
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
ISSN Rivista:
1720-8386
N° Volume:
30
Intervallo pagine:
739-746
Parole chiave:
osteoporosis; microarchitecture; histomorphometry; Rats
Breve descrizione dei contenuti:
Osteoporosis is a severe complication of glucocorticoid treatment. Bisphosphonates are a powerful therapeutic option to prevent osteoporotic fractures. The aims of this study were: a) to determine bone alterations induced by therapy with glucocorticoids (GC); b) to establish the efficacy of risedronate (Ris) in the prevention of these effects. We studied 40 female Sprague-Dawley rats randomly divided into 4 groups of treatment, administered 3 times a week sc: 1. Control: vehicle of methylprednisolone (GC) + vehicle of Ris; 2. Ris: Ris 5 mug/kg body weight vehicle of GC; 3. GC: GC 7 mg/kg + vehicle of Ris; 4. GC+Ris: GC 7 mg/kg, Ris 5 microg/kg. Animals were treated for 30 days and then were sacrificed. Densitometry was performed at baseline and at the end of the treatment. Right tibiae were removed for histomorphometric analyses. The GC group showed a 7% decrease in bone density vs controls (p<0.05), while the GC+Ris group was associated with a 3.5% increase in bone density vs controls (p<0.05). In the GC group, histomorphometric evaluations showed reduced bone volume (BV/TV) and thinning of trabeculae (Tb.Th) vs controls (BV/TV: 31+/-1 vs 35+/-1%, p<0.05; Tb.Th: 43+/-2 vs 50+/-3 microm, p<0.01; Ac.f: 1.8+/-0.2 vs 1.6+/-0.3 N/yr). The GC+Ris group had increased BV/TV and Tb.Th, and reduced Ac.f vs the GC group. Ris also maintained trabecular microarchitecture. At the histological level, glucocorticoid-induced osteoporosis was characterized by decreased bone volume, reduced osteoblastic activity, and deterioration of microarchitecture. Ris counteracted these effects both by prolonging osteoblast activity, and by maintaining bone microarchitecture.
Id prodotto:
40821
Handle IRIS:
11562/313514
depositato il:
26 maggio 2008
ultima modifica:
9 marzo 2021
Citazione bibliografica:
Dalle Carbonare, Luca Giuseppe; Bertoldo, Francesco; Valenti, Maria Teresa; Zordan, S.; Sella, S.; Fassina, A.; Turco, G.; Realdi, G.; Lo Cascio, Vincenzo; Giannini, S., Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. «JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION» , vol. 302007pp. 739-746

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

Progetti Collegati
Titolo Dipartimento Responsabili
Effetto del risedronato nell'osteoporosi cortisonica su modello animale Dipartimento Medicina Luca Giuseppe Dalle Carbonare
<<indietro

Attività

Strutture